Company Filing History:
Years Active: 2015
Title: **Wouter Iwema Bakker: Innovator in Heterocyclic Nuclear Hormone Receptor Modulators**
Introduction
Wouter Iwema Bakker is a notable inventor based in Badhoevedorp, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents.
Latest Patents
Wouter Iwema Bakker holds one patent titled "Heterocyclic Nuclear Hormone Receptor Modulators." This invention encompasses a compound of Formula (I), which includes pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers, and isomers. The compounds derived from his work are particularly useful for treating immunological and oncological conditions, highlighting their potential in critical therapeutic areas.
Career Highlights
Currently, Wouter Iwema Bakker is associated with AbbVie Inc., a company known for its focus on advanced pharmaceuticals and biologics. His research and innovations contribute to the development of new treatments, enhancing the company's portfolio in the medical field.
Collaborations
Throughout his career, Wouter has collaborated with talented individuals in his field, including fellow researchers Kevin Patrick Cusack and Thomas D Gordon. These collaborations have undoubtedly enriched his work and have led to further innovations in pharmaceutical research and development.
Conclusion
Wouter Iwema Bakker exemplifies the spirit of innovation within the pharmaceutical industry. His patent on heterocyclic nuclear hormone receptor modulators promises to pave the way for new treatments, showcasing his dedication to advancing healthcare solutions. His contributions reflect a significant stride towards addressing pressing medical challenges.